Sigma Healthcare is Australia’s largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025... Show more
SIGGF broke above its upper Bollinger Band on August 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 1 similar instances where the stock broke above the upper band. In of the 1 cases the stock fell afterwards. This puts the odds of success at .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 8 cases where SIGGF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 23, 2025. You may want to consider a long position or call options on SIGGF as a result. In of 4 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for SIGGF just turned positive on July 25, 2025. Looking at past instances where SIGGF's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .
SIGGF moved above its 50-day moving average on August 06, 2025 date and that indicates a change from a downward trend to an upward trend.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SIGGF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SIGGF's P/B Ratio (41.494) is very high in comparison to the industry average of (8.342). SIGGF's P/E Ratio (1044.866) is considerably higher than the industry average of (80.556). SIGGF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.432). Dividend Yield (0.002) settles around the average of (0.031) among similar stocks. P/S Ratio (0.977) is also within normal values, averaging (140.909).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGGF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Industry MedicalDistributors
Ticker / NAME | Correlation To SIGGF | 1D Price Change % |
---|---|---|
SIGGF | 100% | N/A |
Distribution Services category (133 stocks) | -2% Poorly correlated | -0.09% |
Medical Distributors category (25 stocks) | -3% Poorly correlated | -0.68% |